Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Vyndaqel is a medication used to reduce cardiovascular death and cardiovascular-related hospitalization in adults by treating wild-type cardiomyopathy or hereditary transthyretin-mediated amyloidosis.
Vyndaqel comes in 20 mg capsules for oral administration.
Vyndaqel should be taken as directed by your doctor. Any questions or concerns should be referred to your doctor or pharmacist.
The recommended dose is to take 80 mg (4 capsules) by mouth once daily.
The active ingredient contained in each Vyndaqel capsule is tafamidis meglumine.
Ammonium hydroxide 28%, brilliant blue FCF, carmine, gelatin, glycerin, iron oxide (yellow), polyethylene glycol 400, polysorbate 80, polyvinyl acetate phthalate, propylene glycol, sorbitan monooleate, sorbitol, and titanium dioxide are the inactive ingredients.
There are no contraindications to Vyndaqel per the most recent Prescribing Information.
No side effects have been reported with treatment with Vyndaqel medication. However, if you develop side effects, contact your doctor right away. You may also report side effects to the Food and Drug Administration (FDA) by calling 1-800-FDA-1088.
Searching for a competitive Vyndaqel price? You can buy Vyndaqel online at a competitive price and with a valid prescription from your doctor here at Canada Pharmacy.